Delivery Order SPE2DB25D3006-SPE2DB25FXHVA
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,260.99, is for the delivery of Cosentyx Unoready 300 mg Pen 2 ml medication. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract was awarded on April 11, 2025 and does not have a set-aside designation. AmerisourceBergen holds a...
This federal contract award, valued at $12,806.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx Unoready 300 mg pen 2 ml. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award, valued at $53,640.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Cosentyx Unoready 300 mg pen, a prescription medication, over the period ending on May 2, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Cosentyx Unoready 300 mg Pen, a specialty pharmaceutical product. The contract has a ceiling value of $9,131.70 and a performance period through April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,939.36 firm fixed-price contract is for the delivery of Cosentyx Unoready 300 mg pen, 2 ml, and has a completion date of May 14, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $33,553.39 for the supply of the medication Cosentyx Unoready 300 mg pen. It is a firm fixed-price contract with a performance period through May 2025. The contract is not designated as a set-aside and is therefore open to full and open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,776.63 firm-fixed-price delivery order is for the supply of Cosentyx Unoready 300 mg pen, a medication used to treat various medical conditions. The contract has an ultimate completion date of May 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,695.43, is for the delivery of Cosentyx Unoready 300 mg pens, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period extending to May 15, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,504.44, is a delivery order for the drug Cosentyx 300mg dose-2 pen/mL. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,555.01, is for the delivery of 4,567,873,131 units of the medication Cosentyx (300 mg pen, 2 mL) with an ultimate completion date of April 11, 2025. This is a firm fixed-price delivery order contract and is not set aside for any specific business category. AmerisourceBergen Drug Corp is the...